Literature DB >> 9563546

Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size.

E J Patterson1, C H Scudamore, D A Owen, A G Nagy, A K Buczkowski.   

Abstract

OBJECTIVE: To determine, in vivo, the effect of radiofrequency ablation (RFA) treatment time and tissue blood flow on the size and shape of the resulting necrotic lesion in porcine liver. SUMMARY BACKGROUND DATA: Radiofrequency ablation is an electrosurgical technique that uses a high frequency alternating current to heat tissues to the point of desiccation (thermal coagulation). Radiofrequency ablation is well established as the treatment of choice for many symptomatic cardiac arrhythmias because of its ability to create localized necrotic lesions in the cardiac conducting system. Until recently, a major limitation of RFA was the small lesion size created by this technique. Development of bipolar and multiple-electrode RFA probes has enabled the creation of larger lesions and therefore has expanded the potential clinical applications of RFA, which includes the treatment of liver tumors. A basic understanding of factors that influence RFA lesion size in vivo is critical to the success of this treatment modality. The optimal RFA technique, which maximizes liver lesion size, has yet to be determined. Theoretically, lesion size varies directly with time of application of the RF current, and inversely with blood flow, but these relationships have not been previously studied in the liver.
METHODS: Six animals underwent hepatic RFA (460 kHz), for 5, 7.5, 10, 12.5, 15, and 20 minutes. Identical, predetermined anatomic areas of the liver were ablated in each animal. Two additional animals underwent 12 RFA treatments -- 6 with vascular inflow occlusion (Pringle maneuver) and 6 with uninterrupted hepatic blood flow. Animals were euthanized and the livers were removed for gross pathologic examination. All lesions were measured in three dimensions and photographed. Tissues were examined by routine histology and by histochemistry to determine viability.
RESULTS: Increasing duration of RFA application from 5 through 20 minutes did not create lesions of larger diameter, but this time increase did predict deeper lesion production (beta = 0.34, p = 0.04). A range of lesion shapes were created from four separate ovals (corresponding to each electrode), to larger ovals intersecting to form a cross, to spheroid lesions. The number of blood vessels in close proximity to the probe tip (within a 1-cm radius from the center of the lesion) strongly predicted minimum lesion diameter (beta = -0.61, p = 0.0001) and lesion volume (beta = -0.56, p = 0.0004). This negative effect of blood flow on lesion size was confirmed experimentally. Radiofrequency ablation lesions created during a Pringle maneuver were significantly larger in all three dimensions than lesions created without a Pringle maneuver: minimum diameter was 3.0 cm (with Pringle) versus 1.2 cm (p = 0.002), maximum diameter was 4.5 cm (with Pringle) versus 3.1 cm (p = 0.002), depth was 4.8 cm (with Pringle) versus 3.1 cm (p < 0.001), and lesion volume was 35.0 cm3 (with Pringle) versus 6.5 cm3 (p < 0.001).
CONCLUSIONS: Blood flow is a strong predictor of all RFA lesion dimensions in porcine liver in vivo, whereas a change of treatment time from 5 to 20 minutes is predictive only of lesion depth, but not diameter or volume.

Entities:  

Mesh:

Year:  1998        PMID: 9563546      PMCID: PMC1191313          DOI: 10.1097/00000658-199804000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

Review 1.  The biophysics of radiofrequency catheter ablation in the heart: the importance of temperature monitoring.

Authors:  D E Haines
Journal:  Pacing Clin Electrophysiol       Date:  1993-03       Impact factor: 1.976

2.  Hepatic ablation using radiofrequency electrocautery.

Authors:  J P McGahan; P D Browning; J M Brock; H Tesluk
Journal:  Invest Radiol       Date:  1990-03       Impact factor: 6.016

Review 3.  Biophysics and pathology of catheter energy delivery systems.

Authors:  S Nath; D E Haines
Journal:  Prog Cardiovasc Dis       Date:  1995 Jan-Feb       Impact factor: 8.194

4.  Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma.

Authors:  S Rossi; M Di Stasi; E Buscarini; L Cavanna; P Quaretti; E Squassante; F Garbagnati; L Buscarini
Journal:  Cancer J Sci Am       Date:  1995 May-Jun

5.  Tumor eradication by radiofrequency therapy. Responses in 21 patients.

Authors:  H H LeVeen; S Wapnick; V Piccone; G Falk
Journal:  JAMA       Date:  1976-05-17       Impact factor: 56.272

Review 6.  Hyperthermia and thermotherapy of benign prostatic hyperplasia: a critical review.

Authors:  C C Schulman; M Vanden Bossche
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

7.  Cryosurgery of liver cancer.

Authors:  G M Onik; D Atkinson; R Zemel; M L Weaver
Journal:  Semin Surg Oncol       Date:  1993 Jul-Aug

8.  Temperature distributions from interstitial rf electrode hyperthermia systems: theoretical predictions.

Authors:  J W Strohbehn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-11       Impact factor: 7.038

9.  Heating efficiency of radiofrequency capacitive hyperthermia for treatment of deep-seated tumors in the peritoneal cavity.

Authors:  R Hamazoe; M Maeta; A Murakami; H Yamashiro; N Kaibara
Journal:  J Surg Oncol       Date:  1991-11       Impact factor: 3.454

10.  Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma.

Authors:  R Hamazoe; Y Hirooka; S Ohtani; T Katoh; N Kaibara
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

View more
  98 in total

1.  Accuracy and effectiveness of laparoscopic vs open hepatic radiofrequency ablation.

Authors:  D J Scott; W N Young; L M Watumull; G Lindberg; J B Fleming; J F Huth; R V Rege; D R Jeyarajah; D B Jones
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

Review 2.  Treatment strategies for hepatocellular carcinoma in cirrhosis.

Authors:  W Scott Helton; Adrian Di Bisceglie; Ravi Chari; Myron Schwartz; Jordi Bruix
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

3.  Bipolar radiofrequency ablation in ex vivo bovine liver with the open-perfused system versus the cooled-wet system.

Authors:  Jeong Min Lee; Joon Koo Han; Se Hyung Kim; Kyu Li Sohn; Seung Hong Choi; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2004-07-10       Impact factor: 5.315

4.  Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model.

Authors:  Cao Guang; Nobuyuki Kawai; Morio Sato; Isao Takasaka; Hiroki Minamiguchi; Shinya Sahara; Kouhei Nakata; Tetsuo Sonomura; Shintaro Shirai; Ichiro Mori; Renjie Yang
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

5.  Thermal ablation for unresectable liver tumours, time to move forward?

Authors:  Gianpiero Gravante
Journal:  World J Gastrointest Surg       Date:  2010-01-27

6.  Laparoscopic radiofrequency ablation of unresectable hepatic malignancies. A phase 2 trial.

Authors:  M H Chung; T F Wood; G J Tsioulias; D M Rose; A J Bilchik
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

7.  Radiofrequency ablation in the liver close to the bile ducts: can intraductal cooling offer protection?

Authors:  U Jersenius; D Arvidsson; J Lindholm; S Anttila; A Elvin
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

Review 8.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

9.  Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.

Authors:  Christoph Niessen; Ernst Michael Jung; Walter A Wohlgemuth; Benedikt Trabold; Michael Haimerl; Andreas Schreyer; Christian Stroszczynski; Philipp Wiggermann
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

10.  Time and dose dependence of pluronic bioactivity in hyperthermia-induced tumor cell death.

Authors:  Tianyi M Krupka; David Dremann; Agata A Exner
Journal:  Exp Biol Med (Maywood)       Date:  2008-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.